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In addition to DNA sequence information, site-specific histone modifications are another important determinant of 
gene expression in a eukaryotic organism. We selected four modification sites in common histones that are known to 
significantly impact chromatin function and generated monoclonal or polyclonal antibodies that recognize each of those 
site-specific modifications. We used these antibodies to demonstrate that the site-specific histone modification levels 
remain relatively constant in different organs of the same organism. We also compared the levels of selected histone 
modifications among several representative organisms and found that site-specific modifications are highly variable among 
different organisms, providing new insight into the evolutionary divergence of specific histone modifications.
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Introduction
Histone modification encompasses a diverse array of 
post-translational covalent modifications that are found 
primarily on the histone N-terminus [1]. Many sites in 
histones are subject to such modifications, which include 
acetylation, phosphorylation, methylation, and ubiquitina-
tion, among others. This type of site-specific histone modi-
fication has been implicated in a lot of important processes 
in eukaryotic cells, such as gene regulation, DNA repair, 
DNA recombination, and chromatin structure remodeling 
[2]. In 2000, Strahl and Allis proposed that distinct histone 
modifications can act sequentially or in combination to 
form a “histone code”, which can be read by other proteins 
to bring about distinct downstream events [3]. This epi-
genetic “code” thus considerably extends the information 
potential of the genetic code [1]. 
In 1989, the first antiserum for site-specific acetylation of 
histone H4 was generated by immunization with synthetic 
peptides [4, 5]. Since then, many antibodies for histone site-
specific modifications have been generated and widely used 
to study histone modification. Although almost 20 years 
has passed since the first antibody against a histone site-
specific modification was developed, the availability and 
affordability of such antibodies is still a limiting factor in 
this area of research [6]. However, commercially produced 
antibodies are expensive and quality may vary from batch 
to batch. Thus an inexpensive and reliable source of high 
affinity antibodies against specific histone modifications is 
important for this area of research. 
Since the development of monoclonal antibody produc-
tion 30 years ago by Cesar Milstein and Georges Kohler, 
it is clear that monoclonal preparation is much better than 
polyclonal serum in achieving high specificity. Owing to the 
small size of the spleen, traditional methods of preparing 
mouse or rat monoclonal antibodies are limited in terms of 
capacity for high throughput screening of highly specific 
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antibodies. The larger spleen of rabbits can help to greatly 
expand the capacity for screening highly specific monoclo-
nal antibodies [7], thus greatly increasing the chances of 
obtaining optimal antibodies. In 1995, Polet et al. generated 
a rabbit plasmacytoma cell line that made the generation 
of rabbit monoclonal antibodies possible [7]. This kind of 
monoclonal antibody is superior in terms of its specificity, 
binding affinity, and bioactivity in a wide variety of biologi-
cal assays. Further, it is believed that rabbits can recognize 
more antigens and epitopes than mice or rats [7]. Thus the 
rabbit system is better suited for production of monoclonal 
antibodies against site-specific histone modifications.
Although histone modification was first discovered more 
than 40 years ago [8], many fundamental questions about 
the biology of histone modifications remain unresolved. 
Previous studies have established that histone modification 
is enormously complicated. In different organisms, the 
site [9], sequence [5, 10], and level of modification [2, 11] 
may be different in some cases, while conserved in oth-
ers. Although there is vast information available about the 
functional role of specific histone modifications [12-14], 
the potential role of histone modification in regulation of 
development has remained elusive. In this study, we report 
the characterization of five antibodies that specifically tar-
get four modified histone sites and the initial application 
of those antibodies to determine the levels of those four 
specific histone modifications in different species as well 
as in different organs of the selected species.
Materials and methods
Antibody preparation, specificity, and utility assays
We synthesized modified peptides corresponding to the histone 
modification sites in Arabidopsis (peptide sequences are described 
in Table 1). All of those peptide sequences are conserved among 
histones found in mammals and higher plants. The rabbit monoclonal 
antibodies were produced in cooperation with Epitomics Biotech Co. 
Ltd. (Hangzhou, China), and the rabbit polyclonal antibodies were 
prepared by the Shanghai Sangon Biotech Company (Shanghai, 
China). We simultaneously expressed full-length His-tagged forms 
of recombinant Arabidopsis histones H3 and H4 in E.coli. The puri-
fied full-length H3 and H4 recombinant histone proteins were used 
as antigens to generate polyclonal antibodies in rabbits specific for 
unmodified histones H3 and H4, respectively. The specificity as-
says performed included immunoblot analysis, dot-blot analysis, 
and peptide inhibition analysis. For the immunoblot analysis, acid-
extracted histone protein samples were separated on 15% sodium 
dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and the proteins 
were transferred to a PVDF membrane. After blocking with freshly 
prepared PBS containing 5% non-fat dry milk (PBS-milk) for 1 h 
at room temperature (RT) with constant agitation, we incubated the 
PVDF membrane with primary antibodies diluted in freshly prepared 
PBS-milk solution for 1 h at RT or 4 ºC overnight. For α-H3K4Me2 
(clone YCA-47-1-4), the final concentration of IgG was 0.1-0.2 
µg/ml; for a-H3K9Ac (clone YCA-28-14), the final concentration of 
IgG was 0.2-0.5 µg/ml; for α-H3K9Me2 (clone YCA-49), the final 
concentration used was 1-1.5 mg/ml; for α-H4K12Ac (polyclonal 
antibody), the dilution was 1:4000; and for α-H4K12 (polyclonal 
antibody), the dilution was 1:2000. After incubating the membrane 
with the secondary antibody (goat anti-rabbit HRP-conjugated IgG, 
Sigma), we developed the signal using the ECL plus Western blot 
detection reagents (Amersham) and analysis procedures.
To perform the dot-blot analysis, we spotted 1 µl of peptide 
diluted in sterile water to 50, 10, 2, and 0.4 pmol/µl onto the PVDF 
membrane and allowed it to air dry. The PVDF membrane was then 
blocked in a manner similar to that used in the immunoblot analysis. 
For the peptide inhibition analysis, about 2 mg of the acid-extracted 
Hela cell histone samples were loaded on an SDS-PAGE mini gel 
in 48 identical lanes and transferred to a PVDF membrane. After 
blocking, we cut the membrane into strips of equal size (with one 
lane each). We added each of the indicated inhibitor peptides to the 
diluted primary antibodies (the final peptide concentrations were 5 
µM for α-H3K4Me2, α-H3K9Ac, and α-H3K9Me2, and 10 µM 
for α-H4K12Ac) and incubated at RT for 1 h before incubating 
the membrane strips with the indicated primary antibodies. The 
procedure following primary antibody incubation is the same as for 
immunoblot analysis. Chromatin immunoprecipitation (ChIP) assays 
were performed as described previously [15]. For α-H3K4Me2, the 
amount of antibody is 2.5 µg/ml; for α-H3K9Ac, it is 3 µg/ml; and 
for α-H4K12Ac (polyclonal antibody), it is 5 µl serum/ml. 
Materials and histone extraction
Six organs (flowering bud, silique, stem, root, rosette leaf, and 
cauline leaf) from our plant model, wild-type Arabidopsis thaliana 
(Col.), were selected for organ-specific analysis of histone modifica-
tion levels. For our mammalian model, the heart, liver, spleen, lung, 
and kidney of adult mouse were used in a similar analysis. Other 
representative species and organ types used included rice leaf, hu-
man-cultured cells (Hela), and Calf thymus. The histones from plant 
materials were isolated as described previously [11]. Acid extractions 
of histones from Hela cells were performed on cell cultures grown 
at 70–90% confluency in 1 × Dulbecco’s-Modified Eagle’s Medium 
(high glucose) supplemented with 10% FBS. To obtain a high acety-
lation levels in our histone sample, we added sodium butyrate (SB), 
which inhibits histone deacetylases, to a final concentration of 5 
mM, which was maintained for 24 h before harvesting the cells. We 
scraped the cells from the plate, and after pelleting and washing the 
cells, the cell pellet was suspended in 5–10 volumes of lysis buffer 
(10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 
1.5 mM PMSF). We added H2SO4 to a final concentration of 0.4 M 
and incubated the suspension on ice for at least 4 h. After spinning 
down to pellet the cell debris, 1/3 volume of 100% TCA was added 
to the supernatant and the mixture was incubated on ice for 30 min. 
The histone proteins were pelleted by centrifugation and were washed 
with acetone. The extracted histone protein pellet was suspended 
with 2 × Loading Buffer and the pH was adjusted with NaOH until 
the color of the loading buffer turned blue. The animal tissues were 
homogenized in cold PBS plus 1 mM freshly added PMSF using a 
glass-Telfon homogenizer. The homogenate was filtered through a 
layer of Miracloth, the filtrate was spun down, and the pellets were 
processed using procedures identical to those for the Hela cells. 
Immunoblot analysis
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or 18% SDS-PAGE and transferred to PVDF (Millipore) membrane 
in Tris-glycine buffer. The membrane was stained by Ponceau S or 
Fast Green. After washing in PBS-T to remove the dye, the membrane 
was blocked by PBS containing 3% non-fat dry milk for 30 min and 
then probed with indicated histone antibody as the primary antibody 
at the same dilution with antibodies assaying. The secondary antibody 
was anti-rabbit IgG at a dilution of 1:8,000 (Sigma). We repeated 
each experiment at least twice with both our own and the Upstate 
antibodies to confirm the reproducibility.
Results
Antibody specificity
Previous studies have established that acetylation of his-
tones H3K9 and H4K12 and methylation of histone H3K4 
are conserved markers for gene activation and euchromatin 
formation, while methylation of histone H3K9 is a marker 
for gene silencing and heterochromatin formation [1, 11, 
16]. These four site-specific modifications with known 
biological function were selected for the production of 
rabbit monoclonal and polyclonal antibodies. The specific 
peptides used as antigens are summarized in Table 1. To 
test antibody specificity, we first tested our site-specific 
antibodies against recombinant histone proteins and the 
acid-extracted histone samples treated with +SB or un-
treated -SB Hela cells. It is anticipated that SB treatment 
will inhibit histone deacetylation and result in high levels 
of acetylated histone accumulation. As shown in Figure 1, 
our site-specific antibodies against H3K9Ac and H4K12Ac 
both detected strong bands in SB-treated samples while 
Table 1 Summary of our antibodies and their tested applications
  Antibody type  Antibody name  Antigen  Tested applications 
  Monoclonal antibody   α-H3K4Me2  KLH conjugated:   Western blot; dot blot; peptide inhibition 
      ART[Me2K]QTAR   assay; immunoprecipitation, chromatin IP
    α-H3K9Me2  KLH conjugated:  Western blot; dot blot; peptide inhibition
      ARTKQTAR[Me2K]STG   assay
    α- H3K9Ac  KLH conjugated:   Western blot; dot blot; peptide inhibition 
      ARTKQTAR[AcK]STG  assay; immunoprecipitation, chromatin IP
  Polyclonal antibody  α-H4K12Ac  KLH conjugated:   Western blot; dot blot; peptide inhibition 
      GKGLG[AcK]GGAKR  assay; immunoprecipitation, chromatin IP
    α-H4K12  KLH conjugated:   Western blot; dot blot; peptide inhibition 
      GKGLGKGGAKR  assay
    α-Histone H3  Recombinant histone H3   Western blot 
      of Arabidopsis with His tag
    α-Histone H4  Recombinant histone H4 of   Western blot
      Arabidopsis with His tag 
Abbreviation: Me2K, lysine with dimethylation; Ac, acetylation.
Figure 1 Antibody specificity tested by immunoblot analysis. The top 
panels show the immunoblots with the five custom-made antibodies 
for site-specific modified histones against acid-extracted proteins 
from Hela cells treated with 5 mM SB for 24 h (H+SB), normal Hela 
cells (H-SB), and recombinant histones (RP). The bottom panels 
show the membrane or the SDS-PAGE gel used for the immunoblot 
to confirm equally loading. Note: the recombinant histone H3 has 
a His-tag at its N terminus, so it looks bigger than native protein. 
Recombinant histone H4 was purchased from the Upstate Company. 
SB is an inhibitor of histone deacetylase.
A Anti-H3K4Me2
H-SB          RP
Anti-H3K9Ac
H+SB         H-SB          RP H-SB        RP
Anti-H3K9Me2 B C
D Anti-H4K12Ac
H+SB         H-SB         RP
Anti-H4K12
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the band was weak or absent in untreated samples. Those 
same antibodies do not react at all with recombinant his-
tone proteins loaded at an amount equivalent to that of 
the extracted histones. The antibodies against H3K4Me2 
and H3K9Me2 can only recognize histones from Hela 
cells, which presumably contain a certain level of those 
site-specific modifications, but these antibodies do not 
recognize recombinant histone H3 proteins at all. In a con-
trol, antibodies against the unmodified H4K12 specifically 
recognized the recombinant histone protein and reacted 
weakly to Hela cell extracts untreated with SB, which are 
expected to have low levels of unmodified histone H4 at 
the K12 site. However, this antibody hardly reacts with 
histone H4 extracted from SB-treated Hela cells, possibly 
owing to higher acetylation and lower unmodified level at 
the K12 site. 
We also used dot-blot analysis to test the specificity of 
our antibodies. As shown in the top panels of Figure 2, all 
five site-specific antibodies, four modified forms and one 
unmodified form, only reacted with the specific peptide and 
not with any other peptides tested, in a range of peptide 
concentrations from a sub-picomolar amount to 50 pmol. 
This result suggested that our antibodies possess the desired 
specificity at the substrate concentration range normally 
used in routine experimentation. 
We further tested our histone modification site-specific 
antibodies for possible crossreactivity using a peptide in-
hibition assay (bottom panels of Figure 2). Again, most of 
our antibodies can only be inhibited by the specific target 
peptides, not by other peptides. Only in the case of our an-
tibody for H3K9Me2, a weak inhibition by the H3K4Me2 
peptide and a moderate inhibition by the H3K27Me2 pep-
tide (Table 1) were observed. This partial inhibition was 
likely due to common amino acids present in the peptides. 
Both the H3K27Me2 and H3K9Me2 shared an “AR[Me2 
K]S” amino acid motif, which might be part of the epitope 
Figure 2 Dot-blot (top panels) and peptide inhibition analyses (bottom panels) test cross reactivity of antibodies. The amounts of 
the corresponding peptides used for dot-blot analysis are indicated at the right. In the peptide inhibition assay, the indicated peptides 
are added to diluted antibodies before being used for immunoblot analysis with acid-extracted proteins from Hela cells untreated 
with SB.
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recognized by this antibody for H3K9Me2. The H3K4Me2 
peptide has an amino acid motif “ART[Me2K]”, similar but 
not identical to that of H3K9Me2 peptide, which could ex-
plain its weak inhibition effect. Since histone H3K9 shares 
a similar flanking amino acid sequence to H3K4 and K27, 
it is a possibility that the antibodies can crossreact to H3K4 
and K27 [17]. A lot of antibodies commercially available 
for H3K9Me2 also seemed to have more or less some de-
gree of crossreactivity, including widely used antibodies 
from Upstate Company (for example, product #05-768). 
Using a different immunization strategy such as immu-
nizing with two-branched peptides, it was claimed that 
the resulting antibodies (Upstate #07-441) for H3K9Me2 
had minimal crossreaction with H3K4Me2 or H3K27Me2 
[17, 18]. However, this strategy of not immunizing with 
original amino-acid sequences might produce antibodies 
that crossreact with other structural features in the organism 
or variant histone proteins. 
Assessment of antibody suitability for immunoprecipitation 
and ChIP analyses
The antibodies for detecting site-specific modifications 
of histones can be powerful tools for analysis of histone 
modification in vivo using immunoblot, immunoprecipita-
tion (IP), and ChIP assays. Our specificity analyses shown 
in Figures 1 and 2 demonstrated our antibodies’ utility for 
immunoblot and dot-blot analyses. We then further exam-
ined our antibodies’ utility in IP and ChIP assays, since it is 
known that some antibodies can be used for one assay but 
Figure 3 Three site-specific histone modification antibodies are 
suitable for immunoprecipitation analysis. Each of the three an-
tibodies (+Ab) for H3K4Me2 (A), H3K9Ac (B), and H4K12Ac 
(C) was used to immunoprecipitate histone samples. A control (-) 
without antibody for all the three antibodies and a pre-immune serum 
(+Pre) control used for polyclonal antibodies were included. The 
immunoprecipitates were separated on 15% SDS-PAGE and blotted 
with antibodies purchased from Upstate corresponding to the same 
histone modification sites. 
A B C -            +Ab -            +Ab -     +Pre      +Ab
Anti-H3K4Me2 Anti-H3K9Ac Anti-H4K12Ac
Figure 4 ChIP analysis of custom-made antibodies compared to 
purchased antibodies. The three diagrams (A-C) display the relative 
enrichment (Y-axis) of corresponding histone modifications at spe-
cific sites, as indicated by the primer numbers described previously 
[19]. All selected primers sites correspond to the regions in the rice 
chromosome 8 centromere. The normalization formula is as follows: 
relative enrichment =(ChIPantibody-Mock) / Input. The results using our 
antibodies and Upstate antibodies are shown side by side.
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not for the others [6]. Among the five specific antibodies we 
have tested, three antibodies (for H3K4Me2, H3K9Ac, and 
H4K12Ac) are able to specifically precipitate their cognate 
modified histones, as confirmed by immunoblot with spe-
cific antibodies against the modified site (Figure 3).
To test antibody specificity and suitability for ChIP as-
says, we compared the performance of our three site-spe-
cific antibodies suitable for IP side-by-side with commercial 
antibodies from the Upstate Company in a ChIP assay 
for modified histones associated with several known rice 
genome sites. We selected six primer pairs corresponding 
to the sequences near the centromere of rice chromosome 
8 reported previously [19] for the ChIP assay. As shown 
in Figure 4, all three of our site-specific antibodies essen-
tially displayed the same histone modification patterns as 
the antibodies purchased from the Upstate Company. We 
also tested the ChIP ability of our antibodies with Arabi-
dopsis and compared it to the ChIP ability of the Upstate 
antibodies. Again, no significant differences were seen 
(data not shown). 
Levels of all four site-specific histone modifications were 
quantitatively similar in different organs of Arabidopsis 
and mouse
It is widely recognized that histone modification is 
a dynamic process. Under different conditions, histone 
modification could be reversibly regulated in some specific 
regions of the genome [20-22]. However, there is currently 
no report of overall changes in site-specific histone modi-
fication levels in different organs of the same organism. 
We thus used our antibodies to test the overall levels of 
four site-specific histone modifications in different organs 
of Arabidopsis and mouse. As shown in Figure 5, no sig-
nificant differences in any of the levels of the site-specific 
modifications were found among distinct organs of either 
Arabidopsis or mouse. This suggests that overall levels of 
site-specific histone modification do not show significant 
differences among different organs in a given organism. 
We also tested modification levels by immunoblot analysis 
using corresponding antibodies from Upstate, and obtained 
resutlts identical to those shown for our antibodies (data 
not shown).
Overall levels of site-specific modifications are highly vari-
able among distinct organisms
Although histones are characterized by highly conserved 
amino-acid sequences, potential differences may exist 
in the specific characteristics and extent of site-specific 
histone modifications. To examine possible differences in 
site-specific histone modifications among several species, 
we analyzed the overall levels of four site-specific histone 
modifications with our antibodies. As shown in Figure 
6, there are some clear differences in the extent of some 
site-specific modifications. For example, in Arabidopsis 
Columbia ecotype, there was a low level of histone H3K9 
dimethylation modification, but other modifications were 
very high comparing with other species. It has been reported 
that histone H3K4 dimethylation, H3K9, and H4K12 
acetylation are correlated positively [1]; whereas all of 
those three site-specific modifications have an inverse cor-
Figure 5 Western blot analysis of overall site-specific histone modification levels among different organs of Arabidopsis (A) and 
mouse (B). The top panels are the stained membranes used for immunoblot analysis, which show the equal loading of the histone 
proteins. The panels below are the results of immunoblot analysis with the corresponding antibodies indicated at the right.
A B Arabidopsis Mouse
Root
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leaf
Cauline 
leaf
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Liver
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Membrane
Anti-H3K4Me2
Anti-H3K9Ac
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unmodified histones or among different modified forms 
constitute an essential tool for studying the functional role of 
site-specific histone modifications. Since the development 
of the first antibody for a modified histone, there has been 
a great demand for reliable and highly specific antibodies 
for various site-specific histone modifications. However, 
most antibodies available in the past are polyclonal anti-
sera, which are always limited in quantity and the quality 
is often highly variable from batch to batch. Thus obtain-
ing monoclonal hybrid myeloma cells that are capable of 
producing unlimited amounts of high-quality monoclonal 
antibodies for each possible site-specific histone modifica-
tion is an important goal. Since hybrid myeloma cells can 
be propagated indefinitely, they provide an inexhaustible 
source for the same high-quality monoclonal antibodies 
for a given site-specific histone modification, while also 
ensuring high reproducibility. Our work demonstrates the 
feasibility of raising a sizable quantity of polyclonal an-
tibody sera from rabbits, while simultaneously preparing 
monoclonal antibodies using the spleen of the same rabbit. 
Using this approach, we have generated antibodies (three 
monoclonal and one polyclonal) for detecting site-specific 
histone modifications.
We compared our custom-made antibodies with anti-
bodies against the same site-specific modified histones 
from a common commercial source (Upstate Company) 
to assess our antibodies’ performance in ChIP and immu-
noblot analyses. For antibodies against H3K4Me2, three 
different products from Upstate were compared: the first is 
a polyclonal rabbit serum (#07-030); the second is rabbit 
monoclonal IgG (clone AW30; #05-790); and the third is 
mouse monoclonal IgM (clone RR302; #05-684). Of the 
three, only rabbit serum can be used in ChIP experiments, 
whereas both monoclonal antibodies of mouse and rabbit 
origin cannot. Our monoclonal IgG antibody can be used 
in ChIP experiments, although the signal is slightly weaker 
compared to the signal generated using Upstate’s rabbit 
polyclonal serum (as shown in Figure 4A). For antibodies 
against H3K9Ac, the Upstate Company has two products. 
One of them is protein A purified rabbit IgG (#06-942) and 
the another is whole rabbit antiserum (#07-352), both of 
which can be used to do ChIP experiments. However, the 
purified rabbit IgG (#06-942) gave a weak signal in the 
ChIP experiment, while the rabbit antiserum (#07-352) 
crossreacted to a non-specific band positioned slightly 
higher than the histone H3 band that can easily be con-
fused with certain site-modified histone H3 forms (data not 
shown). Our monoclonal IgG antibody for H3K9Ac per-
forms well in ChIP experiments and the signal is superior 
to that of the purified rabbit IgG antibody from the Upstate 
Company. For antibodies against H3K9Me2, the Upstate 
Company offers six products, only one (#07-441) of which 
Figure 6 Immunoblot analysis of overall site-specific histone modi-
fication levels among different organisms. The top panel shows a 
representative stained membrane used for immunoblot analysis, to 
show equal loading of the histone proteins from different organisms. 
The panels below show the immunoblot results with the correspond-
ing antibodies indicated at the right. We ran an 18% SDS-PAGE gel to 
assess the efficacy of anti-H3K9Me2. The last two panels were from 
the same Western blot analysis with the Upstate antibodies (#07-441), 
but with a longer (U-EL) or shorter (U-ES) exposure time. The two 
bands (as marked by the triangles) in calf and Arabidopsis Columbia 
ecotype were clearly visible in the shorter exposure Western blot.
Membrane
Hela
Calf
Mouse
Rice
Arabidopsis
Anti-H3K4Me2
Anti-H3K9Ac
Anti-H4K12Ac
Anti-H3K9Me2 (Ours)
Anti-H3K9Me2 (U-EL)
Anti-H3K9Me2 (U-ES)
relation with histone H3K9 dimethylation [1]. This general 
relationship is also evident in the number of total modifi-
cations as shown in Figure 6. Repetition of immunoblot 
analyses using the corresponding antibodies purchased 
from Upstate yield very similar results (data not shown), 
with the exception of H3K9Me2. For the Upstate antibodies 
for H3K9Me2 (#07-441), the antibodies also react with an 
additional band slightly below the expected specific band 
in Calf and Arabidopsis Columbia ecotype samples. This 
was especially evident in the immunoblot with shorter 
exposure time (Figure 6). In both calf and Arabidopsis 
samples, comparison of only the upper specific bands for 
the Upstate antibody and our own antibody suggests that 
the two antibodies perform equally well.
Discussion
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Overall regulation of histone modification
526
npg
can be used in ChIP experiments. Perhaps due to use of a 
different immunization strategy, this antibody can detect 
an additional crossreacting band in calf and Arabidopsis 
Columbia ecotype that was very close to the specific band 
(Figure 6, the last 2 panels). Although our antibody against 
H3K9Me2 is not suitable for ChIP experiments, it performs 
very well in immunoblot analysis. For antibodies against 
H4K12Ac, the Upstate Company offers two products. One 
of them is protein A purified rabbit IgG, and the other is the 
rabbit antiserum depleted of non-acetyl reactive antibod-
ies. Only the latter can be used in ChIP experiments. In a 
side-by-side comparison of the ChIP results (Figure 4C), 
our polyclonal antibody against H4K12Ac shows a much 
stronger signal compared with that of the Upstate antibod-
ies. In immunoblot experiments, our antibody also yields 
a better signal even at high dilutions (data not shown), 
implying the very high affinity of our antibodies. Taken 
together, these results suggest that our antibodies exhibit 
many properties comparable or superior to commercially 
available ones.
Owing to their central function in all eukaryotic organ-
isms, histones are a highly conserved group of proteins. The 
sequence of the most highly conserved group member, his-
tone H4, differs in Arabidopsis and mammals by only two 
amino acids, although plants and animals diverged about 
1.6 billion years ago. However, Arabidopsis and mammals 
display significant differences in histone modification. It 
was thought that as plant cells have retained the property of 
totipotency, or ability to regenerate the entire plant from a 
single cell, and maintained the ability to de-differentiate, the 
establishment and maintenance of epigenetic information 
might differ significantly from animals [9]. Some species 
might display special histone modification patterns [2] 
and modification sites (http://research.nhgri.nih.gov/his-
tones/index.shtml) that were not observed in other species 
[2]. The same modification might function differently in 
unrelated species [1, 2, 11, 14, 16]. Previous studies also 
showed that some site-specific histone modification differ-
ences between animals and plants exist at a genome-wide 
level [11]. Thus, it is of great interest to know if the extent 
of site-specific modifications varies among different organs 
of a given species and among different species. 
Our studies revealed that there is no overall difference 
in the extent of site-specific modifications among different 
organs of a given organism. Thus, the overall role of histone 
modification in the regulation of an organism’s develop-
ment appears to be limited. The level of a site-specific 
histone modification of any organ can be an indicator for 
the level in the whole organism. However, this observa-
tion clearly does not rule out potential differences among 
localized and specific regions of a chromosome during the 
development of an organism [2, 17, 18].
However, there is a great variation in the overall level 
of site-specific histone modifications among distinct or-
ganisms. This may reflect the different developmental 
patterns and life cycles of different organisms [9]. It is 
interesting to note that our data on the overall extent of 
histone modification among organisms examined further 
substantiated the previously observed positive correla-
tion among histone modifications (H3K4Me2, H3K9Ac, 
H4K12Ac) associated with gene activation. Our data also 
corroborated an inverse correlation among histone modi-
fications (H3K9Me2) associated with gene repression at 
the local chromatin and gene level. These findings further 
suggest roles for these site-specific histone modifications 
in modulating gene activity. The availability of this set of 
site-specific histone modification antibodies will provide 
essential tools for further examining the functional impli-
cations of histone modification in various organisms and 
developmental processes.
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